| Megan Metelak, OTR/L | |
|
7505 Country Club Dr, Golden Valley, MN 55427-4501 | |
| (763) 450-6902 | |
| Not Available |
| Full Name | Megan Metelak |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 7505 Country Club Dr, Golden Valley, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083043707 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 104527 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Metelak, OTR/L 7505 Country Club Dr, Golden Valley, MN 55427-4501 Ph: () - | Megan Metelak, OTR/L 7505 Country Club Dr, Golden Valley, MN 55427-4501 Ph: (763) 450-6902 |
News Archive
US Oncology, Inc. partnered with the Association of Community Cancer Centers, Association of Oncology Social Work, American Society for Clinical Oncology, Community Oncology Alliance, Oncology Nursing Society and the National Patient Advocate Foundation in hosting a panel discussion on Capitol Hill today to examine the benefits of oral chemotherapy in cancer care, as well as challenges in its prescribing, accessibility and adherence in the current health care system.
WebMD Health Corp. announced today the preliminary results of its tender offer to purchase up to 5,700,000 shares of its common stock at a price of $37.00 per share, which expired at 5:00 p.m., New York City time on December 10, 2009.
Johns Hopkins researchers report that the deletion of any single gene in yeast cells puts pressure on the organism's genome to compensate, leading to a mutation in another gene. Their discovery, which is likely applicable to human genetics because of the way DNA is conserved across species, could have significant consequences for the way genetic analysis is done in cancer and other areas of research, they say.
Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, cardiovascular, wound care and orthopedic areas, announced today its results for the first quarter ended March 31, 2011.
The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association and the Heart Rhythm Society.
› Verified 5 days ago
Monica L Mommsen, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3915 Golden Valley Road, Courage Center, Golden Valley, MN 55422 Phone: 763-588-0811 Fax: 763-520-0355 | |
Caryn Faith Erickson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6701 Country Club Dr, Struthers Parkinsons Center, Golden Valley, MN 55427 Phone: 952-993-5495 | |
Molly Peterson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7505 Country Club Dr, Golden Valley, MN 55427 Phone: 763-450-6900 | |
Megan Anderson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7505 Country Club Dr, Golden Valley, MN 55427 Phone: 763-450-6902 Fax: 763-545-2016 | |
Lee Ann Mae Mateffy, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3915 Golden Valley Road, Courage Center, Golden Valley, MN 55422 Phone: 763-520-0431 Fax: 763-520-0355 | |
Dr. Stephanie Nga Frager, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7505 Country Club Dr, Golden Valley, MN 55427 Phone: 763-450-6902 |